APA Alıntı

Halpern, A. B., Othus, M., Huebner, E. M., Scott, B. L., Becker, P. S., Percival, M. M., . . . Walter, R. B. (2018). Phase 1/2 Trial of GCLAM with Dose-Escalated Mitoxantrone for Newly Diagnosed AML or Other High-Grade Myeloid Neoplasms. Leukemia.

Chicago Stili Alıntı

Halpern, Anna B., et al. "Phase 1/2 Trial of GCLAM With Dose-Escalated Mitoxantrone for Newly Diagnosed AML or Other High-Grade Myeloid Neoplasms." Leukemia 2018.

MLA Alıntı

Halpern, Anna B., et al. "Phase 1/2 Trial of GCLAM With Dose-Escalated Mitoxantrone for Newly Diagnosed AML or Other High-Grade Myeloid Neoplasms." Leukemia 2018.